Afivastobart (AB598) is a human ENTPD1 ( CD39 )-targeting monoclonal antibody with antineoplastic activity.Afivastobart binds as a monoclonal antibody to modulate Homo sapiens ENTPD1 activity.Afivastobart constitutes a glycoform alfa immunoglobulin G1-kappa monoclonal antibody [1].
In Vitro, Afivastobart is produced by Chinese hamster ovary (CHO-K1) cells[1].
References:
[1]. WHO Drug Information - Volume 39, No. 4. 2025.
In Vitro, Afivastobart is produced by Chinese hamster ovary (CHO-K1) cells[1].
References:
[1]. WHO Drug Information - Volume 39, No. 4. 2025.
















